Cargando…
Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory
Twelve high-risk alpha human papillomavirus (HPV) genotypes cause approximately 690,000 cancer cases annually, with cervical and oropharyngeal cancer being the two most prominent types. HPV testing is performed in laboratory settings for various applications of a clinical, epidemiological, and resea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446865/ https://www.ncbi.nlm.nih.gov/pubmed/37439692 http://dx.doi.org/10.1128/jcm.01403-22 |
_version_ | 1785094418633588736 |
---|---|
author | Poljak, Mario Cuschieri, Kate Alemany, Laia Vorsters, Alex |
author_facet | Poljak, Mario Cuschieri, Kate Alemany, Laia Vorsters, Alex |
author_sort | Poljak, Mario |
collection | PubMed |
description | Twelve high-risk alpha human papillomavirus (HPV) genotypes cause approximately 690,000 cancer cases annually, with cervical and oropharyngeal cancer being the two most prominent types. HPV testing is performed in laboratory settings for various applications of a clinical, epidemiological, and research nature using a range of clinical specimens collected by clinicians or by individuals (self-collected specimens). Here, we reflect on the importance and justification of using the right test for the right application and provide practical updates for laboratories either participating in or anticipating involvement in HPV testing in three specimen types, namely, urine, blood, and oral specimens, which are considered “alternative” specimens by many. In addition to clinician-collected cervical samples and self-collected cervicovaginal samples, first-void urine is emerging as a credible specimen for HPV-based cervical cancer screening, triage of HPV screen-positive women, monitoring HPV vaccine impact, and HPV testing in groups for which a less invasive sample is preferred. Detection of cell-free DNA (including HPV DNA) in blood has great promise for the early detection of HPV-attributable oropharyngeal cancer (HPV-AOC) and potentially other HPV-driven cancers and as an adjunct prognostic marker in long-term tumor surveillance, including treatment response. The moderate sensitivity of HPV testing in oral rinses or swabs at HPV-AOC diagnosis prevents its use in HPV-AOC secondary prevention but represents a promising prognostic tool in HPV-AOC tertiary prevention, where the HPV persistence in oral rinses throughout treatment may predict early HPV-AOC recurrences and/or the development of secondary HPV-AOC. The increasing sophistication of specific collection devices designed for alternative samples and the enhanced precision of novel molecular technologies are likely to support the evolution of this field and catalyze potential translation into routine practice. |
format | Online Article Text |
id | pubmed-10446865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-104468652023-08-24 Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory Poljak, Mario Cuschieri, Kate Alemany, Laia Vorsters, Alex J Clin Microbiol Minireview Twelve high-risk alpha human papillomavirus (HPV) genotypes cause approximately 690,000 cancer cases annually, with cervical and oropharyngeal cancer being the two most prominent types. HPV testing is performed in laboratory settings for various applications of a clinical, epidemiological, and research nature using a range of clinical specimens collected by clinicians or by individuals (self-collected specimens). Here, we reflect on the importance and justification of using the right test for the right application and provide practical updates for laboratories either participating in or anticipating involvement in HPV testing in three specimen types, namely, urine, blood, and oral specimens, which are considered “alternative” specimens by many. In addition to clinician-collected cervical samples and self-collected cervicovaginal samples, first-void urine is emerging as a credible specimen for HPV-based cervical cancer screening, triage of HPV screen-positive women, monitoring HPV vaccine impact, and HPV testing in groups for which a less invasive sample is preferred. Detection of cell-free DNA (including HPV DNA) in blood has great promise for the early detection of HPV-attributable oropharyngeal cancer (HPV-AOC) and potentially other HPV-driven cancers and as an adjunct prognostic marker in long-term tumor surveillance, including treatment response. The moderate sensitivity of HPV testing in oral rinses or swabs at HPV-AOC diagnosis prevents its use in HPV-AOC secondary prevention but represents a promising prognostic tool in HPV-AOC tertiary prevention, where the HPV persistence in oral rinses throughout treatment may predict early HPV-AOC recurrences and/or the development of secondary HPV-AOC. The increasing sophistication of specific collection devices designed for alternative samples and the enhanced precision of novel molecular technologies are likely to support the evolution of this field and catalyze potential translation into routine practice. American Society for Microbiology 2023-07-13 /pmc/articles/PMC10446865/ /pubmed/37439692 http://dx.doi.org/10.1128/jcm.01403-22 Text en Copyright © 2023 Poljak et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Minireview Poljak, Mario Cuschieri, Kate Alemany, Laia Vorsters, Alex Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory |
title | Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory |
title_full | Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory |
title_fullStr | Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory |
title_full_unstemmed | Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory |
title_short | Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory |
title_sort | testing for human papillomaviruses in urine, blood, and oral specimens: an update for the laboratory |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10446865/ https://www.ncbi.nlm.nih.gov/pubmed/37439692 http://dx.doi.org/10.1128/jcm.01403-22 |
work_keys_str_mv | AT poljakmario testingforhumanpapillomavirusesinurinebloodandoralspecimensanupdateforthelaboratory AT cuschierikate testingforhumanpapillomavirusesinurinebloodandoralspecimensanupdateforthelaboratory AT alemanylaia testingforhumanpapillomavirusesinurinebloodandoralspecimensanupdateforthelaboratory AT vorstersalex testingforhumanpapillomavirusesinurinebloodandoralspecimensanupdateforthelaboratory |